Back to results
US 10,093,627 B2Granted
Tetrahydroquinoline derivatives and their use as Epac inhibitors
AssigneesInstitut National De La Sante Et De La Recherche Medicale (Inserm), Universite Paul Sabatier Toulouse III, Universite Paris-Sud, Universite D'Orleans
InventorsFrank Lezoualc'h, Rodolphe Fischmeister, Malik Bisserier, Pascal Bouyssou, Jean-Paul Blondeau, Delphine Courilleau
Life of this patent
Estimating the term…
Abstract
The invention relates to tetrahydroquinoline derivatives and their use in the treatment and/or the prevention of a disease wherein the Epac protein is involved, such as inflammation, cancer, vascular diseases, kidney diseases, cognitive disorders and cardiac diseases.
Claims1
A composition, comprising a pharmaceutically acceptable carrier, and compound having the following formula:
Dependencies are inferred from the claim text.